These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26736068)

  • 1. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
    Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
    Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
    Zhang F; Lin H; Gu A; Li J; Liu L; Yu T; Cui Y; Deng W; Yan M; Li J; Yao M
    J Proteomics; 2014 May; 102():125-36. PubMed ID: 24667143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
    Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
    Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC.
    Lin HC; Zhang FL; Geng Q; Yu T; Cui YQ; Liu XH; Li J; Yan MX; Liu L; He XH; Li JJ; Yao M
    J Proteome Res; 2013 Jul; 12(7):3423-33. PubMed ID: 23713811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
    An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
    Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
    Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
    Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
    Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
    J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
    Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
    Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
    Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
    Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.
    Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; Lang K; Zänker KS; Metzger R; Schneider PM; Gerke V; Thomas M; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2004 Aug; 64(16):5564-9. PubMed ID: 15313892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.
    Schmidt LH; Spieker T; Koschmieder S; Schäffers S; Humberg J; Jungen D; Bulk E; Hascher A; Wittmer D; Marra A; Hillejan L; Wiebe K; Berdel WE; Wiewrodt R; Muller-Tidow C
    J Thorac Oncol; 2011 Dec; 6(12):1984-92. PubMed ID: 22088988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
    Planque C; Kulasingam V; Smith CR; Reckamp K; Goodglick L; Diamandis EP
    Mol Cell Proteomics; 2009 Dec; 8(12):2746-58. PubMed ID: 19776420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of RON in small and non-small cell lung cancers.
    Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R
    Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
    Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
    J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.